From Surf Wiki (app.surf) — the open knowledge base
Cyclopropylmescaline
| Field | Value | |||
|---|---|---|---|---|
| verifiedrevid | 408409035 | |||
| image | Cyclopropylmescaline.svg | |||
| image_class | skin-invert-image | |||
| width | 250px | |||
| image2 | Cyclopropylmescaline-3d-sticks.png | |||
| image_class2 | bg-transparent | |||
| width2 | 250px | |||
| routes_of_administration | Oral | |||
| class | Serotonin [5-HT2 receptor](5-ht2-receptor) agonist; Serotonin [5-HT2A receptor](5-ht2a-receptor) agonist; Serotonergic psychedelic; Hallucinogen | |||
| ATC_prefix | None | |||
| onset | ≤20 minutes | |||
| duration_of_action | 12–18 hours | |||
| CAS_number_Ref | ||||
| CAS_number | 207740-23-6 | |||
| PubChem | 44350143 | |||
| ChemSpiderID_Ref | ||||
| ChemSpiderID | 21106288 | |||
| UNII_Ref | ||||
| UNII | D9268U4GS8 | |||
| ChEMBL_Ref | ||||
| ChEMBL | 421458 | |||
| synonyms | CPM; 4-Cyclopropylmethoxy-3,5-methoxyphenethylamine | |||
| IUPAC_name | 2-[4-(cyclopropylmethoxy)-3,5-dimethoxyphenyl]ethan-1-amine | |||
| C | 14 | H=21 | N=1 | O=3 |
| SMILES | COc2cc(cc(OC)c2OCC1CC1)CCN | |||
| StdInChI_Ref | ||||
| StdInChI | 1S/C14H21NO3/c1-16-12-7-11(5-6-15)8-13(17-2)14(12)18-9-10-3-4-10/h7-8,10H,3-6,9,15H2,1-2H3 | |||
| StdInChIKey_Ref | ||||
| StdInChIKey | LNTBHKZMYJTHTH-UHFFFAOYSA-N |
| Drugs.com =
| elimination_half-life =
Cyclopropylmescaline (CPM), also known as 4-cyclopropylmethoxy-3,5-dimethoxyphenethylamine, is a psychedelic drug of the phenethylamine and scaline families related to mescaline. It is taken orally and has a very long duration of 12 to 18hours.
Use and effects
In his book PiHKAL (Phenethylamines I Have Known and Loved) and other publications, Alexander Shulgin lists the dose range of CPM as 60 to 80mg and its duration as 12 to 18hours. Its onset is within 20minutes and peak effects occurred at around 1.5hours. The drug is approximately 5times as potent as mescaline and is longer-lasting in comparison.
The effects of CPM have been reported to include remarkable closed-eye visuals and fantasy, mental imagery synchronized with music, not much in terms of open-eye visuals, heightened tactile awareness, not much insight, daydreaming about eroticism, feeling exposed and vulnerable, sounds including voices and even music feeling intrusive and irritating, and interference with sleep and feeling tired due to its very long duration.
Interactions
Pharmacology
Pharmacodynamics
CPM acts as a serotonin 5-HT2 receptor full agonist, including of the serotonin 5-HT2A, 5-HT2B, and 5-HT2C receptors.
Chemistry
Synthesis
The chemical synthesis of CPM has been described.
Analogues
Analogues of CPM include mescaline, escaline, proscaline, allylescaline, methallylescaline, and cycloproscaline, among others.
History
CPM was described in the scientific literature by Alexander Shulgin by 1994. Subsequently, it was further described by Shulgin in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved).
Society and culture
Legal status
Canada
CPM is not a controlled substance in Canada as of 2025.
References
References
- {{CitePiHKAL [https://www.erowid.org/library/books_online/pihkal/pihkal037.shtml CPM Entry in ''PiHKAL'']
- (1994). "Structure-activity relationships of the classic hallucinogens and their analogs". NIDA Res Monogr.
- (2003). "Hallucinogens: A Forensic Drug Handbook". Elsevier Science.
- (December 2023). "Identification of 5-HT2A receptor signaling pathways associated with psychedelic potential". Nat Commun.
- (October 2025). "The polypharmacology of psychedelics reveals multiple targets for potential therapeutics". Neuron.
- "Controlled Drugs and Substances Act".
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Cyclopropylmescaline — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report